Search
Cintredekin besudotox
go.drugbank.com/drugs/DB05305InvestigationalCintredekin besudotox is made from a human protein, Interleukin 13 (IL13), linked to a bacterial toxin, _Pseudomonas exotoxin_ (PE). The IL13 portion binds to receptors on the tumor. … Cintredekin besudotox has been developed as a specific tumor-targeting agent, which is administered by positive-pressure convection-enhanced delivery (CED) directly to brain tissue at risk for residual
CRx-139
go.drugbank.com/drugs/DB05744ExperimentalIt is a dissociated steroid designed to enhance the immuno-modulatory activity of a low-dose glucocorticoid steroid without a comparable increase in steroid-related side effects. … CRx-139 is an oral synergistic combination drug candidates with novel mechanisms of action targeting multiple biological pathways simultaneously.
Tyrosol
go.drugbank.com/drugs/DB16855ExperimentalCategories: Compounds used in a research, industrial, or household settingMeptazinol
go.drugbank.com/drugs/DB13478ExperimentalCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromePromegestone
go.drugbank.com/drugs/DB13602ExperimentalCategories: Sex Hormones and Modulators of the Genital SystemPhenazocine
go.drugbank.com/drugs/DB13606ExperimentalCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeEosin
go.drugbank.com/drugs/DB13706InvestigationalCategories: Compounds used in a research, industrial, or household settinggamma-Tocopherol
go.drugbank.com/drugs/DB15394Experimentalgamma-Tocopherol is under investigation in clinical trial NCT00836368 (In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics).
Synonyms: D-gamma-TocopherolCategories: Compounds used in a research, industrial, or household settingAlisertib
go.drugbank.com/drugs/DB05220InvestigationalAlisertib is a novel aurora A kinase inhibitor under investigation for the treatment of various forms of cancer.
TAK-475
go.drugbank.com/drugs/DB05317InvestigationalTAK-475 is a "squalene synthase inhibitor", a type of cholesterol-lowering drug that has not yet been brought to market.